ECNU breakthrough in fight against the “Immortal Cancer”
On July 15, 2024, the achievements made by ECNU’s scientific research team, composed of Du Bing, Liu Mingyao, and Li Dali from the School of Life Sciences, were published online in Cell, a top international journal, marking the first global report on the use of allogeneic universal CAR-T to treat rheumatic immune diseases.ECNU’s scientific research team composed of Du Bing, Liu Mingyao, and L...